Erythropoietin treatment in patients on maintenance haemodialysis in dialysis centers of South-East region of Poland--present state.
South-East region of Poland includes six voivodeships, with about 3.6 mln of inhabitants. Nine dialysis centers work in this region with 273 places to perform maintenance haemodialysis outside Lublin, and 53 places in Lublin Clinic Center. The aim of this paper was to analyse the state of r-Hu EPO treatment in chronic dialysis patients. We would like to compare the treatment possibilities in the clinic unit with other haemodialysis units of our region and with data from Western Europe that we know from EDTA report. Simultaneously we decided to estimate real possibilities of iron treatment monitoring. As it is well known correct management of iron supplementation treatment, allows for the significant reduction of r-Hu EPO administration.
Ksiazek
A
A
Katedra i Klinika Nefrologii Akademii Medycznej, Lublinie.
Majdan
M
M
Jaroszyński
A
A
Swatowski
A
A
Krzywicka
A
A
Kolibska
E
E
Gotner
S
S
Kosicki
A
A
Piaseczny
W
W
Sokalski
A
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D001772:Blood Cell Count; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005293:Ferritins / Q000097:blood; D006801:Humans; D007501:Iron / Q000097:blood; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D011044:Poland; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D006435:Renal Dialysis; D014168:Transferrin / Q000032:analysis
D011994:Recombinant Proteins; D014168:Transferrin; D004921:Erythropoietin; D005293:Ferritins; D007501:Iron